Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS: A Pilot Study
This is an open-label clinical trial to determine the safety of rTMS and efficacy in improving depression symptoms, quality of life and cognition deficits among patients with Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative disorders.
Indication: ALS
Modality: medical device
Target: rTMS
Sponsor: Hospital for Special Surgery, New York
Source URL: ClinicalTrials.gov
Source updated: Nov 14, 2022
Ingested: Jun 18, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: rTMS
View original source fields
Condition raw: ALS
Condition normalized: ALS
Modality raw: medical device
Modality normalized: medical device
Target raw: rTMS
Target normalized: rTMS